CURE - Oncology & Cancer News for Patients & Caregivers
WEBBoruzu Approved by FDA For Multiple Myeloma, Mantle Cell Lymphoma. By Alex Biese. September 6th 2024. CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.
Love Lost: The Effects of Cancer on Marriage and Relationships
WEBOct 28, 2021 · A cancer diagnosis also can have a practical impact, negatively affecting job security, finances, basic family dynamics and more. “It can be very difficult to navigate,” Corbett says. Receiving a diagnosis of cancer also can have a devastating emotional impact on the caregiving spouse or partner.
All News | Blogs - Curetoday
WEBA Lesson About Mindset I Learned Overcoming a Less than 10% Survival Rate. Steve Rubin. September 13th 2024. Looking back at my experience with osteosarcoma, I realized that managing the mental game was half the battle, especially with so much negativity.
Long-Term Follow-Up Shows Keytruda Continues to Improve
WEBFeb 1, 2021 · Keytruda (pembrolizumab) continued to demonstrate a clinically meaningful improvement in overall and progression-free survival, compared with docetaxel, in patients with previously treated, PD-L1–positive advanced non-small cell lung cancer (NSCLC) after more than five years of follow-up, according to results from the phase 2/3 KEYNOTE-010 study presented at the 2020 World Conference on Lung ...
How I Used Turkey Tail Mushrooms Alongside Cancer Treatment
WEBJan 8, 2024 · Turkey tail is a shelf mushroom, named that because of the way they grow on dead and decaying trees like little rows of shelves. Because of its positive effects on the immune system. Studies, such as one published in 2023 in the journal, Cureus, show that use of the mushroom improved outcomes among patients who use it …
Star of TV's "The Little Couple" Shares What Having a Rare
WEBMar 2, 2016 · Jennifer Arnold. Jennifer Arnold, a star of the television show “The Little Couple,” was the keynote speaker in December at CURE’s 2015 MPN Heroes event, which recognized seven individuals and one organization for offering above-and-beyond support to patients with myeloproliferative neoplasms.. While on hand for the Orlando event, Arnold sat down with CURE to discuss her experiences ...
FDA Approves Zirabev, an Avastin Biosimilar, for Five ... - Curetoday
WEBJun 28, 2019 · The Food and Drug Administration (FDA) has approved Zirabev (bevacizumab-bvzr) — a biosimilar to Avastin (bevacizumab) — for the treatment of five types of cancer: metastatic colorectal cancer; unresectable, locally advanced, recurrent or metastatic non-squamous non-small cell lung cancer (NSCLC); recurrent glioblastoma; metastatic renal cell carcinoma (RCC); and persistent, recurrent or ...
Calquence Shows Favorable Long-Term Outcomes in Treatment
WEBJun 4, 2020 · Long-term data presented at the 2020 ASCO Virtual Scientific Program demonstrated that Calquence (acalabrutinib) is safe and effective in patients with treatment-naïve chronic lymphocytic leukemia, supporting its use in the front line setting in this population. “Targeted inhibition of Bruton's tyrosine kinase, or BTK, has improved clinical ...
Amy Robach Discusses Her Cancer Experience - Curetoday
WEBNov 6, 2018 · Robach, 45, is a survivor of stage 2 invasive breast cancer. Despite her physician’s disapproval, she made the radical decision to get a double mastectomy. During that procedure, a second malignant tumor was found in her left breast. Today, she remains on tamoxifen, a drug that helps prevent the recurrence of hormone-driven breast cancers.
Pluvicto Improves Survival Without Progression in Certain Patients …
WEBOct 23, 2023 · Pluvicto improved progression-free survival in certain patients with prostate cancer, recent research showed. Treatment with Pluvicto (177-Lu-PSMA-617) improved the duration of time when a patient’s disease did not progress with a favorable safety profile in patients with metastatic castration-resistant prostate cancer (mCRPC) who were taxane ...